Lantz Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.33M Sell
20,986
-1,247
-6% -$138K 0.58% 46
2025
Q1
$2.49M Sell
22,233
-3,367
-13% -$377K 0.68% 38
2024
Q4
$2.36M Sell
25,600
-214
-0.8% -$19.8K 0.63% 44
2024
Q3
$2.16M Buy
25,814
+894
+4% +$75K 0.59% 49
2024
Q2
$1.71M Buy
24,920
+840
+3% +$57.6K 0.53% 58
2024
Q1
$1.76M Buy
24,080
+1,470
+7% +$108K 0.57% 56
2023
Q4
$1.83M Buy
22,610
+705
+3% +$57.1K 0.66% 45
2023
Q3
$1.64M Sell
21,905
-218
-1% -$16.3K 0.65% 42
2023
Q2
$1.71M Sell
22,123
-1,004
-4% -$77.4K 0.67% 43
2023
Q1
$1.92M Sell
23,127
-2,711
-10% -$225K 0.8% 30
2022
Q4
$2.22M Sell
25,838
-702
-3% -$60.3K 1.01% 23
2022
Q3
$1.64M Buy
26,540
+220
+0.8% +$13.6K 0.85% 29
2022
Q2
$1.63M Buy
26,320
+448
+2% +$27.7K 0.73% 31
2022
Q1
$1.54M Buy
25,872
+2,409
+10% +$143K 0.63% 47
2021
Q4
$1.7M Buy
23,463
+945
+4% +$68.6K 0.78% 37
2021
Q3
$1.57M Buy
22,518
+539
+2% +$37.7K 0.81% 36
2021
Q2
$1.51M Buy
21,979
+706
+3% +$48.6K 0.78% 38
2021
Q1
$1.38M Buy
21,273
+770
+4% +$49.8K 0.78% 40
2020
Q4
$1.2M Buy
20,503
+390
+2% +$22.7K 0.75% 39
2020
Q3
$1.27M Buy
20,113
+846
+4% +$53.5K 0.85% 36
2020
Q2
$1.48M Sell
19,267
-2,610
-12% -$201K 1.07% 27
2020
Q1
$1.64M Buy
21,877
+4,352
+25% +$325K 1.28% 12
2019
Q4
$1.14M Sell
17,525
-3,320
-16% -$216K 0.67% 50
2019
Q3
$1.28M Buy
20,845
+1,095
+6% +$67.4K 0.87% 38
2019
Q2
$1.36M Buy
19,750
+85
+0.4% +$5.85K 0.92% 35
2019
Q1
$1.28M Buy
+19,665
New +$1.28M 0.93% 36